<DOC>
	<DOCNO>NCT02949791</DOCNO>
	<brief_summary>Cytoreductive surgery ( CRS ) hyperthermic intraperitoneal chemotherapy ( HIPEC ) promise therapy peritoneal carcinomatosis ( PC ) various origin . Rather pharmacokinetic advantage , uptake chemotherapy tumor tissue propose best pharmacologic endpoint assure efficacy HIPEC . The primary endpoint present phase II randomize study test whether increased intra abdominal pressure ( IAP ) HIPEC could : - enhance penetration cisplatin residual neoplastic normal tissue ; - elicit change pharmacokinetic advantage cisplatin . Secondary endpoint evaluate : - impact high IAP intraoperatory hemodynamic respiratory parameter ; - impact short-term surgical outcome ( hospital stay , morbidity , mortality ) . Patients affected PC colorectal cancer pseudomyxoma peritonei , submit complete cytoreduction ( residual disease &lt; 2.5mm ) would eligible study . HIPEC perform use closed abdomen technique cisplatin + mitomycin-C . Patients randomly assign HIPEC low IAP ( 8-12 mmHg ) high IAP ( 18-22 mmHg ) . IAP measure use bladder catheter . High IAP obtain increase volume perfusate . Thirty-eight patient ( 19 study group ) enrol 30 month . The randomized group stratify accord tumor type .</brief_summary>
	<brief_title>HIPEC Using High Intra-abdominal Pressure</brief_title>
	<detailed_description>Patients affect peritoneal metastasis colorectal cancer pseudomyxoma peritonei , submit complete cytoreduction ( residual disease &lt; 2.5mm ) would eligible study . Residual resectable tumour nodule 0.5 1.0 cm leave behind cytoreduction collected end HIPEC purpose study . HIPEC perform use closed abdomen technique cisplatin ( 42mg/L perfusate ) + mitomycin-C ( 3.3mg/m2/L perfusate ) 60 minute , 42.5째C . Patients randomly assign HIPEC low IAP ( 8-12 mmHg ) high IAP ( 18-22 mmHg ) . IAP measure use bladder catheter . Patients high IAP group strictly monitor perfusion regard hemodynamic/respiratory parameter . During HIPEC , perfusate blood sample collect every 10 minute . Additional sample arterial blood collect 70 , 90,120,180 240 minute . After completion HIPEC residual tumor tissue , normal peritoneum muscular fascia sample determination cisplatin concentration . Blood sample immediately centrifuge separate plasma . An aliquot plasma store -30째C total platinum determination . Another aliquot ultrafiltered centrifugation membrane cut-off 5000 Da ultrafilterable platinum determination . The ultrafiltrate store -30째C analysis . Perfusate sample follow procedure blood sample . Tissues sample store -80째C analysis . Platinum determination perform use Inductive Coupled Plasma Mass Spectrometry ( ICP-MS ) system Thermo Scientific prepare calibration curve atomic platinum . Fluid sample simply dilute ICP-MS examination tissue desiccate , digested mixture nitric acid oxygen water , evaporate dryness prior determination . The investigator compare follow outcome study group : tumor tissue concentration cisplatin ; area curve ( AUC ) ratio perfusate UF concentration cisplatin time time plasma UF concentration time time ; in-hospital stay ; systemic toxicity ( NCI-CTCAE.v3 ) , morbidity , mortality . Thirty eight patient ( 19 group ) would need detect increase cisplatin concentration 20 ng/mg tumor tissue patient submit high-IAP HIPEC , assume alfa=0.05 power=0.90 standard deviation 15 ng . Accrual time 30 month . The randomized group stratify accord tumor type .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Pseudomyxoma Peritonei</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<criteria>1 . Histological diagnosis primary peritoneal carcinomatosis colorectal origin pseudomyxoma peritonei 2 . Patients submit complete cytoreduction residual tumor &lt; 2.5 mm 3 . Patients end cytoreduction present laboratorial hemodynamic parameter set following : Mean arterial pressure &gt; 65 mmHg Heart rate : &lt; 100 bpm Central venous pressure &gt; 4 mmHg Cardiac index &gt; 2.2 Central venous oxygen saturation ( ScvO2 ) &gt; 72 % , Haemoglobin &gt; 8.0 gr/dl . 4 . Informed consent sign patient procedure . Severe hemodynamic and/or respiratory instability cytoreduction precludes HIPEC .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cisplatin</keyword>
	<keyword>HIPEC</keyword>
	<keyword>Intra abdominal pressure</keyword>
	<keyword>tissue drug concentration</keyword>
</DOC>